Literature DB >> 28779395

Multi-parametric MRI in cervical cancer: early prediction of response to concurrent chemoradiotherapy in combination with clinical prognostic factors.

Wei Yang1, Jin Wei Qiang2, Hai Ping Tian3, Bing Chen1, Ai Jun Wang1, Jian Guo Zhao1.   

Abstract

OBJECTIVE: To investigate the prediction of response to concurrent chemoradiotherapy (CCRT) through a combination of pretreatment multi-parametric magnetic resonance imaging (MRI) with clinical prognostic factors (CPF) in cervical cancer patients.
METHODS: Sixty-five patients underwent conventional MRI, diffusion-weighted imaging (DWI), and dynamic contrast-enhanced MRI (DCE-MRI) before CCRT. The patients were divided into non- and residual tumour groups according to post-treatment MRI. Pretreatment MRI parameters and CPF between the two groups were compared and prognostic factors, optimal thresholds, and predictive performance for post-treatment residual tumour occurrence were estimated.
RESULTS: The residual group showed a lower maximum slope of increase (MSIL) and signal enhancement ratio (SERL) in low-perfusion subregions, a higher apparent diffusion coefficient (ADC) value, and a higher stage than the non-residual tumour group (p < 0.001, p = 0.003, p < 0.001, and p < 0.001, respectively). MSIL and ADC were independent prognostic factors. The combination of both measures improved the diagnostic performance compared with individual MRI parameters. A further combination of these two factors with CPF exhibited the highest predictive performance.
CONCLUSIONS: Pretreatment MSIL and ADC were independent prognostic factors for cervical cancer. The predictive capacity of multi-parametric MRI was superior to individual MRI parameters. The combination of multi-parametric MRI with CPF further improved the predictive performance. KEY POINTS: • Pretreatment MSI L and ADC were independent prognostic factors for post-treatment residual tumours. • The residual groups showed lower MSI L , higher ADC and higher stage. • The predictive capacity of multi-parametric MRI was superior to individual MRI parameters. • The combination of multi-parametric MRI with CPF exhibited the highest predictive performance.

Entities:  

Keywords:  Cervical cancer; Concurrent chemoradiotherapy; Diffusion-weighted imaging; Dynamic contrast-enhanced MR imaging; Magnetic resonance imaging

Mesh:

Year:  2017        PMID: 28779395     DOI: 10.1007/s00330-017-4989-3

Source DB:  PubMed          Journal:  Eur Radiol        ISSN: 0938-7994            Impact factor:   5.315


  33 in total

1.  MRI in diagnosis of pathological complete response in breast cancer patients after neoadjuvant chemotherapy.

Authors:  Yan-Ling Li; Xiao-Peng Zhang; Jie Li; Kun Cao; Yong Cui; Xiao-Ting Li; Ying-Shi Sun
Journal:  Eur J Radiol       Date:  2014-12-03       Impact factor: 3.528

Review 2.  MR microcirculation assessment in cervical cancer: correlations with histomorphological tumor markers and clinical outcome.

Authors:  N A Mayr; H Hawighorst; W T Yuh; M Essig; V A Magnotta; M V Knopp
Journal:  J Magn Reson Imaging       Date:  1999-09       Impact factor: 4.813

3.  Evaluation of therapeutic response to concurrent chemoradiotherapy in patients with cervical cancer using diffusion-weighted MR imaging.

Authors:  Hyun Su Kim; Chan Kyo Kim; Byung Kwan Park; Seung Jae Huh; Bohyun Kim
Journal:  J Magn Reson Imaging       Date:  2012-09-27       Impact factor: 4.813

4.  Dynamic contrast-enhanced 3-T MR imaging in cervical cancer before and after concurrent chemoradiotherapy.

Authors:  Jae-Hun Kim; Chan Kyo Kim; Byung Kwan Park; Sung Yoon Park; Seung Jae Huh; Bohyun Kim
Journal:  Eur Radiol       Date:  2012-06-01       Impact factor: 5.315

5.  Diffusion-weighted MRI in cervical cancer.

Authors:  Patrick Z McVeigh; Aejaz M Syed; Michael Milosevic; Anthony Fyles; Masoom A Haider
Journal:  Eur Radiol       Date:  2008-01-12       Impact factor: 5.315

6.  Characterizing at-Risk Voxels by Using Perfusion Magnetic Resonance Imaging for Cervical Cancer during Radiotherapy.

Authors:  Zhibin Huang; Nina A Mayr; Simon S Lo; John C Grecula; Jian Z Wang; Guang Jia; William Tc Yuh
Journal:  J Cancer Sci Ther       Date:  2012-09

Review 7.  Novel imaging techniques as response biomarkers in cervical cancer.

Authors:  Vanessa N Harry
Journal:  Gynecol Oncol       Date:  2010-02       Impact factor: 5.482

8.  Hypoxia-inducible factor-1α protects cervical carcinoma cells from apoptosis induced by radiation via modulation of vascular endothelial growth factor and p53 under hypoxia.

Authors:  Zhichao Fu; Dongsheng Chen; Huihua Cheng; Fengmei Wang
Journal:  Med Sci Monit       Date:  2015-01-27

9.  Relating Doses of Contrast Agent Administered to TIC and Semi-Quantitative Parameters on DCE-MRI: Based on a Murine Breast Tumor Model.

Authors:  Menglin Wu; Li Lu; Qi Zhang; Qi Guo; Feixiang Zhao; Tongwei Li; Xuening Zhang
Journal:  PLoS One       Date:  2016-02-22       Impact factor: 3.240

10.  Apparent Diffusion Coefficient (ADC) value: a potential imaging biomarker that reflects the biological features of rectal cancer.

Authors:  Yiqun Sun; Tong Tong; Sanjun Cai; Rui Bi; Chao Xin; Yajia Gu
Journal:  PLoS One       Date:  2014-10-10       Impact factor: 3.240

View more
  7 in total

1.  Quantitative diffusion MRI of the abdomen and pelvis.

Authors:  Diego Hernando; Yuxin Zhang; Ali Pirasteh
Journal:  Med Phys       Date:  2021-10-08       Impact factor: 4.506

2.  MRI-based radiomics for pretreatment prediction of response to concurrent chemoradiotherapy in locally advanced cervical squamous cell cancer.

Authors:  Xiaomiao Zhang; Qi Zhang; Xiaoduo Yu; Xinming Zhao; Yan Chen; Sicong Wang; Jieying Zhang; Jusheng An; Lizhi Xie
Journal:  Abdom Radiol (NY)       Date:  2022-10-12

Review 3.  Combining Radiotherapy With Anti-angiogenic Therapy and Immunotherapy; A Therapeutic Triad for Cancer?

Authors:  Ruben S A Goedegebuure; Leonie K de Klerk; Adam J Bass; Sarah Derks; Victor L J L Thijssen
Journal:  Front Immunol       Date:  2019-01-14       Impact factor: 7.561

4.  Changes in magnetic resonance T2-weighted imaging signal intensity correlate with concurrent chemoradiotherapy response in cervical cancer.

Authors:  Bing Liu; Wan-Ling Ma; Guang-Wen Zhang; Zhen Sun; Jin-Man Zhong; Meng-Qi Wei; Hua Yang; Li-Chun Wei; Yi Huan
Journal:  J Contemp Brachytherapy       Date:  2019-02-28

5.  The value of DWI in predicting the response to synchronous radiochemotherapy for advanced cervical carcinoma: comparison among three mathematical models.

Authors:  Hui Zhang; Yuyang Zhou; Jie Li; Pengjuan Zhang; Zhenzhen Li; Junwu Guo
Journal:  Cancer Imaging       Date:  2020-01-14       Impact factor: 3.909

Review 6.  Diffusion-weighted MRI to detect early response to chemoradiation in cervical cancer: A systematic review and meta-analysis.

Authors:  Vanessa N Harry; Sunil Persad; Bharat Bassaw; David Parkin
Journal:  Gynecol Oncol Rep       Date:  2021-10-18

7.  DCE-MRI Quantitative Parameters as Predictors of Treatment Response in Patients With Locally Advanced Cervical Squamous Cell Carcinoma Underwent CCRT.

Authors:  Bing Liu; Zhen Sun; Wan-Ling Ma; Jing Ren; Guang-Wen Zhang; Meng-Qi Wei; Wei-Huan Hou; Bing-Xin Hou; Li-Chun Wei; Yi Huan; Min-Wen Zheng
Journal:  Front Oncol       Date:  2020-10-29       Impact factor: 6.244

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.